98%
921
2 minutes
20
Background And Purpose: Heterozygous HTRA1-related cerebral small vessel disease (hHTRA1-CSVD) presents diagnostic challenges due to its clinical and imaging similarities with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and sporadic cerebral small vessel disease (CSVD). Recently, the "chocolate chip sign" around the midbrain has been proposed as a potential imaging marker for hHTRA1-CSVD. However, the diagnostic value of similar findings around the pons remains unclear. This study aims to assess the diagnostic performance of the "pons chocolate chip sign" in distinguishing hHTRA1-CSVD from CADASIL and sporadic CSVD.
Materials And Methods: This cross-sectional study included seven patients with hHTRA1-CSVD, twenty-seven patients with CADASIL and twelve patients with sporadic CSVD. All participants underwent 7.0T magnetic resonance imaging (MRI). The "pons chocolate chip sign" was defined as round or ovoid hypointense dots (≥ 2 mm in diameter) surrounding the pons on T2*-weighted gradient echo images. The number of chocolate chips was independently assessed by two blinded neurologists. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis, with genetic diagnosis as the gold standard.
Results: The "pons chocolate chip sign" was found in 5/7 patients with hHTRA1-CSVD, compared to 2/27 in CADASIL and 0/12 in sporadic CSVD. ROC analysis revealed that it exhibited good discriminatory capability for hHTRA1-CSVD (area under the curve [AUC] = 0.84, 95% confidence interval [CI]: 0.63-1.00, P = 0.004). At an optimal cutoff of chocolate chips ≥ 1, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and Youden index were 71.42%, 94.87%, 71.42%, 94.87%, and 0.66, respectively. When the cutoff was increased to ≥ 3 chocolate chips, the specificity improved further, reaching 100%.
Conclusions: The "pons chocolate chip sign" demonstrates high specificity for hHTRA1-CSVD and good discriminatory performance in differentiating hHTRA1-CSVD from CADASIL and sporadic CSVD.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12382193 | PMC |
http://dx.doi.org/10.1186/s12883-025-04374-3 | DOI Listing |
BMC Neurol
August 2025
Department of Neurology, Peking University First Hospital, Beijing, China.
Background And Purpose: Heterozygous HTRA1-related cerebral small vessel disease (hHTRA1-CSVD) presents diagnostic challenges due to its clinical and imaging similarities with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and sporadic cerebral small vessel disease (CSVD). Recently, the "chocolate chip sign" around the midbrain has been proposed as a potential imaging marker for hHTRA1-CSVD. However, the diagnostic value of similar findings around the pons remains unclear.
View Article and Find Full Text PDFNeurol Sci
July 2025
Department of Neurology, Peking University First Hospital, Xicheng District, Beijing, China.
We report a 59-year-old man with heterozygous HTRA1-related cerebral small vessel disease (hHTRA1-CSVD) presenting with vascular dementia and gait disturbances. Susceptibility-weighted imaging revealed multiple round or ovoid hypointensities around the midbrain, pons, and medulla-termed the "brainstem chocolate chip sign." This feature may represent leptomeningeal venous abnormalities and may serve as a specific imaging marker for hHTRA1-CSVD.
View Article and Find Full Text PDFNat Commun
July 2025
State Key Laboratory of Photonics and Communications, School of Information Science and Electronic Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
The exponential growth of data traffic propelled by cloud computing and artificial intelligence necessitates advanced optical interconnect solutions. While wavelength division multiplexing (WDM) enhances optical module transmission capacity, chromatic dispersion becomes a critical limitation as single-lane rates exceed 200 Gbps. Here we demonstrate a 4-channel silicon transmitter achieving 1 Tbps aggregate data rate through integrated adaptive dispersion compensation.
View Article and Find Full Text PDFToxicol Res
July 2025
Department of MetaBioHealth, Sungkyunkwan University, Suwon, 16419 Republic of Korea.
During drug development, it is crucial to ensure that a drug exhibits effective activity in its target cells and organs. However, regardless of its effectiveness, a drug cannot be administered to patients if it exhibits toxicity in vivo. Based on pharmacokinetics, most drugs are cleared from the liver after entering the body, and only the remaining fraction reaches the target organ to exert therapeutic effects.
View Article and Find Full Text PDFComput Biol Med
July 2025
Department of Computer and Information Engineering, Khalifa University, Abu Dhabi, United Arab Emirates. Electronic address:
Central Apnea (CA) and Central Hypopnea (CH) are sleep disorders arising from the brain's inability to signal respiratory muscles, potentially leading to severe complications such as heart failure. This study presents a novel system for automating CA and CH event detection in sleep apnea patients using a feedforward neural network (FdNN) architecture integrated into an ultra-low-power System-on-Chip (SoC) with chin electromyography (EMG) signals. The SoC achieves sub-1-mW power consumption through careful co-optimization of the FdNN architecture, hardware design, and circuit-level considerations, ensuring efficient operation with high-accuracy event detection.
View Article and Find Full Text PDF